# Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain

> **NCT03009500** · PHASE3 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 3 (actual)

## Conditions studied

- Neuralgia
- Peripheral Neuropathic Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Depo-Medrol Injectable Product
- **OTHER:** Saline (Sodium Chloride) solution
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT03009500
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-03
- **Final completion:** 2019-06
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009500, "Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03009500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
